Holen Sie sich die Stockscreener-App
44.62
0.63%
0.2931
Definium Therapeutics Inc Aktie (DFTX) Neueste Nachrichten
Definium Therapeutics Announces New Employee Inducement Grants - Business Wire
Earnings call transcript: Definium’s Q1 2026 EPS miss overshadows strategic advances - Investing.com
Definium earnings on deck as pivotal psychedelic trial data looms By Investing.com - Investing.com India
DFTXDefinium Therapeutics Inc Volatility & Greeks - Finviz
Enterprise value to EBITDA forward of Definium Therapeutics, Inc. – NASDAQ:DFTX - TradingView
LSD therapy biotech Definium fends off trade-secret lawsuit - Reuters
DFTX Stock Clocks Best Day In Over Two Years On 'Best-Case' Clinical Results For Oral Lysergide In Depression - Stocktwits
Definium Therapeutics (DFTX) Institutional Ownership 2026 - MarketBeat
Definium Therapeutics Completes $805 Million Upsized Public Offering - Global Legal Chronicle
DFTX Maintained by Canaccord Genuity -- Price Target Lowered to $58 - GuruFocus
Hogan Lovells advises Definium Therapeutics, Inc. in Upsized Public Offering - Legal Desire Media and Insights
Is Definium Therapeutics, Inc. (DFTX) Stock Poised for Further Gains After Positive Emerge Trial Update? - Insider Monkey
Top 3 Health Care Stocks That May Keep You Up At Night In June - Benzinga
Canaccord cuts Definium Therapeutics stock price target on share count - Investing.com
CCORF Maintains Definium Therapeutics(DFTX.US) With Buy Rating, Cuts Target Price to $58 - Moomoo
Analysts Are Bullish on Top Healthcare Stocks: Crinetics Pharmaceuticals (CRNX), Definium Therapeutics (DFTX) - The Globe and Mail
Definium Therapeutics stock hits 52-week high at 47.01 USD By Investing.com - Investing.com Nigeria
Definium Therapeutics stock hits 52-week high at 47.01 USD - Investing.com
Definium Therapeutics, Inc.(NasdaqGS:DFTX) dropped from Russell Small Cap Comp Value Benchmark - marketscreener.com
Definium Therapeutics, Inc.(NasdaqGS: DFTX) dropped from Russell 3000E Index - marketscreener.com
Definium Therapeutics, Inc.(NasdaqGS:DFTX) dropped from Russell 3000E Growth Benchmark - marketscreener.com
Definium Therapeutics, Inc.(NasdaqGS: DFTX) dropped from Russell Microcap Index - marketscreener.com
Definium Therapeutics, Inc.(NasdaqGS:DFTX) dropped from Russell 3000 Value Benchmark - marketscreener.com
Definium Therapeutics, Inc.(NasdaqGS:DFTX) dropped from Russell Microcap Growth Benchmark Index - marketscreener.com
10 Best Biotech Stocks to Buy According to Analysts - Insider Monkey
DFTX Vs CMPS: Which Stock Has More Upside From Trump’s New Psychedelic Therapy Push? - Stocktwits
Wall Street Analysts Are Bullish on Top Healthcare Picks - The Globe and Mail
Definium Therapeutics, Inc.(NasdaqGS:DFTX) dropped from Russell 3000E Value Benchmark - marketscreener.com
Price to sales forward of Definium Therapeutics, Inc. – NASDAQ:DFTX - TradingView
Enterprise value to revenue forward of Definium Therapeutics, Inc. – NASDAQ:DFTX - TradingView
Enterprise value to EBIT forward of Definium Therapeutics, Inc. – HAM:MMQ0 - TradingView
Price to sales forward of Definium Therapeutics, Inc. – HAM:MMQ0 - TradingView
Price to earnings forward of Definium Therapeutics, Inc. – NASDAQ:DFTX - TradingView
Price to book forward of Definium Therapeutics, Inc. – HAM:MMQ0 - TradingView
Price to earnings forward of Definium Therapeutics, Inc. – HAM:MMQ0 - TradingView
LifeSci Capital Maintains Definium Therapeutics(DFTX.US) With Buy Rating, Maintains Target Price $63 - Moomoo
ETFs Investing in Definium Therapeutics, Inc. Stocks - TradingView
Price to earnings ratio of Definium Therapeutics, Inc. – HAM:MMQ0 - TradingView
Definium Therapeutics Prices Offering of Nearly 20.6M Shares at $34.00 Each >DFTX - Moomoo
Definium Therapeutics (DFTX) CLO sells 13,008 shares to cover RSU taxes - Stock Titan
Definium Therapeutics (DFTX) CMO sells 10,035 shares to cover RSU taxes - Stock Titan
Definium raises $805 million after positive Phase III depression data - The Pharma Letter
Definium Therapeutics, Inc. Announces Closing - Moomoo
Definium Therapeutics (DFTX) CFO disposes 3,013 shares to cover RSU taxes - Stock Titan
Form 144 DEFINIUM THERAPEUTICS For: 25 June By Investing.com - Investing.com South Africa
Definium Therapeutics prices $700M upsized public offering at $34.00 a share - MSN
Top Definium Therapeutics (DFTX) Competitors 2026 - MarketBeat
Definium Therapeutics, Inc. Announces Closing of $805 Million Upsized Public Offering, Including Full Exercise of the Underwriters’ Option to Purchase Additional Shares - BioSpace
Definium Therapeutics closes $805 million stock offering - Investing.com UK
Definium Therapeutics Company Profile & Introduction - Moomoo
Definium Therapeutics, Inc. Actuals & Estimates (NASDAQ:DFTX) - TradingView
Definium Therapeutics closes $805 million stock offering By Investing.com - Investing.com South Africa
Definium Therapeutics (DFTX) Short Interest & Short Float | Updated Jun 2026 - MarketBeat
Definium raises $805M as underwriters take full extra share allotment - Stock Titan
DFTX (NASDAQ: DFTX) affiliate files to sell 13,008 restricted shares - Stock Titan
DFTX (NASDAQ) director sale: 2,867 shares via Morgan Stanley on 06/25/2026 - Stock Titan
3,013-share sale notice by insider (DFTX, NASDAQ: DFTX) - Stock Titan
Form 144: DFTX insider lists 10,035 shares (DFTX) - Stock Titan
DFTX (NASDAQ: DFTX) filing to sell 29,208 common shares on 06/25/2026 - Stock Titan
Definium Therapeutics (DFTX) Stock Forum and Discussion - Moomoo
$Definium Therapeutics (DFTX.US)$ has moved up too far from moving averages . RSI 88. Day 2 . Taking short position. 30% - Moomoo
Definium Therapeutics (DFTX) Lands Phase 3 Win And Raises $700 Million For DT120 - Sahm
Definium Therapeutics (DFTX) Sees 21.8% Surge in Stock Price - GuruFocus
1.21%
3.14%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):